Genetic Polymorphism of CYP2C19*2: Risk Stratification of Poor Metabolizers of Proton Pump Inhibitors” give examples like this for recent project study for m.pharm
Your credits are exhausted. You can purchase a top-up or subscribe to a plan to continue using Orris. If you're already subscribed, your daily credits will reset tomorrow.
This is a shared conversation. Sign in to Orris to start your own chat.